JPND Launches €30 Million Call for Multinational Research on Personalised Medicine for Neurodegenerative Diseases

The EU Joint Programme – Neurodegenerative Disease Research (JPND) initiative has announced a joint transnational call for multinational research on personalised medicine for neurodegenerative diseases.
Applications are closed
6 months ago

January 9, 2019 - PARIS--(BUSINESS WIRE)

Neurodegenerative diseases are debilitating and still largely untreatable conditions. These diseases are characterised by a large variability in their origins, mechanisms and clinical expression, requesting treatments that will need to take into account all these specificities. Deciphering this variability is one of the biggest challenges in the treatment of neurodegenerative diseases and the way forward is Precision Medicine, supported by highly personalised approaches for the greatest benefit of the patients.

In partnership with the European Commission, JPND is inviting multinational research teams to submit proposals for ambitious, innovative and multidisciplinary collaborative research projects to change the trajectory of these diseases through the development of Precision Medicine approaches.

JPND has chosen to focus in the area of Precision Medicine, which relates to the targeting of specific elements responsible for pathology in a given individual at a particular point in time. It is an emerging approach for disease prevention, diagnosis and treatment that takes into account individual variability in genes, biological/molecular characteristics together with environmental and lifestyle factors.

Proposals submitted under this call must focus on Precision Medicine in one or several of the following research areas:

  • Diagnosis (e.g. biomarkers, imaging data, omics approaches, big data analyses).
  • Prevention (e.g. biomarkers for studying novel treatments and interventions, co-morbidities, digital technologies, stratification within cohort studies and clinical trials).
  • Care (e.g. improvement of social and health care systems, molecular profiling, imaging, lifestyle data).

Proposals must also relate to any or several of the following neurodegenerative diseases: Alzheimer’s disease and other dementias, Parkinson’s disease and PD-related disorders, Prion diseases, Motor Neuron diseases, Hungtington’s disease, Spinocerebellar ataxia and Spinal muscular atrophy.

Pre-proposals must be submitted no later than 15:00h C.E.T. on March 12, 2019.

Source: JPND 

Illustration Photo: Scientists working on the development of companion diagnostics at QIAGEN's research and development laboratory in in Manchester, UK. (credits: QIAGEN / Flickr Creative Commons Attribution-NonCommercial-NoDerivs 2.0 Generic (CC BY-NC-ND 2.0))

Read more

If your organization published a call for proposals, call for projects or call for applications for Startups, Entrepreneurs or Researchers, we will be happy to publish it free of charge on our website.
Please drop your pdf files and/or your url link on our WhatsApp +85577778919 or email to us at info@adalidda.com


Thank You
Adalidda's Team

Comments

Hannah Bayley
Hannah Bayley
2 months ago

Multi-level search is launched and initiated for the investigation on different topics. The process of the research and bestessayservicereviews is approved for the students. New topics and these have been explored for the brick paces for the citizens.